161 related articles for article (PubMed ID: 25956659)
21. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
Caldwell-Brown D; Stern RS; Lin AN; Carter DM
N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal complications of epidermolysis bullosa in children.
Freeman EB; Köglmeier J; Martinez AE; Mellerio JE; Haynes L; Sebire NJ; Lindley KJ; Shah N
Br J Dermatol; 2008 Jun; 158(6):1308-14. PubMed ID: 18363753
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
24. [Role of cutaneous pinch grafts in the healing of patients with dystrophic epidermolysis bullosa wounds: report of four cases].
Claude O; Binder JP; Bustamante K; Blanchet-Bardon C; Andrivon F; Revol M; Servant JM
Ann Chir Plast Esthet; 2005 Jun; 50(3):189-96. PubMed ID: 15963838
[TBL] [Abstract][Full Text] [Related]
25. High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.
Kühl T; Mezger M; Hausser I; Handgretinger R; Bruckner-Tuderman L; Nyström A
Mol Ther; 2015 Aug; 23(8):1368-1379. PubMed ID: 25858020
[TBL] [Abstract][Full Text] [Related]
26. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
[TBL] [Abstract][Full Text] [Related]
27. Dystrophic calcinosis cutis in autosomal recessive dystrophic epidermolysis bullosa.
Bhari N; Bharti P
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31540927
[TBL] [Abstract][Full Text] [Related]
28. [G-CSF - primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children].
Styczyński J; Debski R; Krenska A; Wysocki M
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1112-6. PubMed ID: 19531818
[TBL] [Abstract][Full Text] [Related]
29. Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation.
Hussein AA; Sharma S; Al-Zaben A; Frangoul H
Pediatr Transplant; 2014 Sep; 18(6):625-30. PubMed ID: 25041793
[TBL] [Abstract][Full Text] [Related]
30. Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa.
Bar J; Sarig O; Lotan-Pompan M; Dassa B; Miodovnik M; Weinberger A; Sprecher E; Segal E; Samuelov L
Clin Exp Dermatol; 2021 Oct; 46(7):1223-1229. PubMed ID: 33682945
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds.
Yan H; Chen J; Peng X
Burns; 2012 Sep; 38(6):877-81. PubMed ID: 22652468
[TBL] [Abstract][Full Text] [Related]
32. Use of a keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa.
Than MP; Smith RA; Cassidy S; Kelly R; Marsh C; Maderal A; Kirsner RS
J Dermatolog Treat; 2013 Aug; 24(4):290-1. PubMed ID: 22208480
[TBL] [Abstract][Full Text] [Related]
33. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations.
Schumann H; Has C; Kohlhase J; Bruckner-Tuderman L
Br J Dermatol; 2008 Aug; 159(2):464-9. PubMed ID: 18565177
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
Chen YK; Jiang XM; Gong JP
J Vasc Surg; 2008 May; 47(5):1058-65. PubMed ID: 18358673
[TBL] [Abstract][Full Text] [Related]
35. Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa.
Huitema L; Phillips T; Alexeev V; Igoucheva O
Exp Dermatol; 2021 Dec; 30(12):1724-1733. PubMed ID: 34142388
[TBL] [Abstract][Full Text] [Related]
36. Case report: rapidly healing epidermolysis bullosa wound after ablative fractional resurfacing.
Krakowski AC; Ghasri P
Pediatrics; 2015 Jan; 135(1):e207-10. PubMed ID: 25535263
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of allogeneic cord blood platelet gel on wounds of dystrophic epidermolysis bullosa patients after pseudosyndactyly surgery.
Torkamaniha E; Amirkhani MA; Dahmardehei M; Rebulla P; Piccin A; Hortamani S; Heidari-Kharaji M; Mansouri P; Hamidieh AA; Nilforoushzadeh MA
Wound Repair Regen; 2021 Jan; 29(1):134-143. PubMed ID: 33009688
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity.
Kirkorian AY; Weitz NA; Tlougan B; Morel KD
Pediatr Dermatol; 2014; 31(1):33-7. PubMed ID: 24224977
[TBL] [Abstract][Full Text] [Related]
39. Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa.
Raymakers AJN; Kesselheim AS; Mostaghimi A; Feldman WB
JAMA Dermatol; 2024 Mar; 160(3):297-302. PubMed ID: 38294784
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
Fuentes I; Yubero MJ; Morandé P; Varela C; Oróstica K; Acevedo F; Rebolledo-Jaramillo B; Arancibia E; Porte L; Palisson F
Int Wound J; 2023 Mar; 20(3):774-783. PubMed ID: 36787273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
